Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|July 30, 2021
Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung CancerXinqing Lin, Haiyi Deng, Yilin Yang, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2022
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data studyXinqing Lin, Haiyi Deng, Suyang Li, et al.
Clinical Lung Cancer|January 23, 2025
Phase I Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation-Supported Dose-Intensified Chemotherapy With Adebrelimab as First-Line Treatment for Extensive-Stage Small Cell Lung CancerMing Liu, Wenhui Guan, Xiaohong Xie, et al.
Frontiers in Immunology|January 31, 2022
Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor PneumonitisXinqing Lin, Jiaxi Deng, Haiyi Deng, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2025
The survival analysis of stage III and IV inoperable lung large cell neuroendocrine carcinoma and the role of LIPI in immunological stratificationRu Li, Wenxia Xie, Rui Chen, et al.
Clinical Lung Cancer|January 27, 2019
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five CasesYinyin Qin, Guoying Gao, Xiaohong Xie, et al.
Human Vaccines & Immunotherapeutics|August 1, 2023
Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patientsXiaohong Xie, Maolin Zhou, Liqiang Wang, et al.
Translational Lung Cancer Research|December 15, 2022
Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case reportGuihuan Qiu, Suyang Li, Bingliang Li, et al.
Heliyon|November 25, 2024
Biological and clinical characteristics of non-small cell lung cancer non-specific subtypeXiaohong Xie, Chen Zeng, Fei Wang, et al.
Frontiers in Oncology|July 10, 2024
The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patientsNi Sun, Ru Li, Haiyi Deng, et al.
Pageof 9